Girinath G Pillai

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Anti Inflammatory

Tyrosine Kinase

Breast Cancer Cells

Top Venues

Scientific reports

Foods (Basel, Switzerland)

Chemical biology & drug design

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Siva S Panda, Queen L Tran, Pragya Rajpurohit, Girinath G Pillai, Sean J Thomas, Allison E Bridges, Jason E Capito, Muthusamy Thangaraju, Vinata B Lokeshwar
Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Vidhya Prakash, Akshaya S Krishnan, Reshma Ramesh, Chinchu Bose, Girinath G Pillai, Bipin G Nair, Sanjay Pal
Synergistic Effects of Limosilactobacillus fermentum ASBT-2 with Oxyresveratrol Isolated from Coconut Shell Waste. Foods (Basel, Switzerland) 10 (11) (2021)
Ambili Unni P, Sajitha Lulu Sudhakaran, Girinath G Pillai
Review on druggable targets of key age-associated properties regulated by therapeutic agents. Chemical biology & drug design 96 (4) (2020)
Jitendra Kumar Srivastava, Girinath G Pillai, Hans Raj Bhat, Amita Verma, Udaya Pratap Singh
Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase. Scientific reports 7 (1) (2017)